Mayo Clinic researchers and a team of collaborating scientists from across the country have determined the comparative effectiveness of nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin and several supplements in preventing the recurrence of advanced neoplasia (polyps that are the precursor of colorectal cancer) after polyp removal.
Regular use of aspirin by people living in Shanghai, China, was associated with decreased risk for developing pancreatic cancer, according to data published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Data from the new study and meta-analysis of data from 18 other studies suggest that over the past two decades, as the general population’s use of aspirin has increased, the effect of aspirin in decreasing pancreatic cancer risk has become more pronounced.
Inflammation has long been associated with cancer. COX enzymes play an integral role in inflammation. NSAIDs act on COX enzymes to reduce inflammation. The efficacy of NSAIDs was considered in cancer prevention and on survival thereafter. Aspirin was found to be the most superior NSAID but it also prolonged the survival of cancer patients and provided anti-thrombotic protection.
MRI and MRI targeted biopsies are recommended by the American Urological Association and the Society of Abdominal Radiology, according to a new consensus statement in The Journal of Urology®
If, when, and how men with negative biopsies for prostate cancer should continue to be monitored are questions facing patients and health care providers in view of concerns and criticisms about over detection, overtreatment, and under detection due to sampling errors in standard biopsies.
Jason Attard, Miriam Dalmas & Kathleen England
- TheSynapse Magazines 2016
Alfred Grech, Alexandra Baldacchino
- TheSynapse Magazines 2014